ImmunologybioRxiv
Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of inhibiting SARS-CoV-2 replication and induced inflammation
C. A. Fuzo, R. B. Martins, T. F. C. Fraga-Silva…·M. Dias-Baruffi
This paper identifies celastrol as a potential drug for treating Covid-19 by inhibiting SARS-CoV-2 replication and reducing IL-6 secretion in infected cells.
DOI 10.1002/ddr.21982